These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

262 related articles for article (PubMed ID: 20570944)

  • 1. Human immune system development and rejection of human islet allografts in spontaneously diabetic NOD-Rag1null IL2rgammanull Ins2Akita mice.
    Brehm MA; Bortell R; Diiorio P; Leif J; Laning J; Cuthbert A; Yang C; Herlihy M; Burzenski L; Gott B; Foreman O; Powers AC; Greiner DL; Shultz LD
    Diabetes; 2010 Sep; 59(9):2265-70. PubMed ID: 20570944
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A new immunodeficient hyperglycaemic mouse model based on the Ins2Akita mutation for analyses of human islet and beta stem and progenitor cell function.
    Pearson T; Shultz LD; Lief J; Burzenski L; Gott B; Chase T; Foreman O; Rossini AA; Bottino R; Trucco M; Greiner DL
    Diabetologia; 2008 Aug; 51(8):1449-56. PubMed ID: 18563383
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rejection of human islets and human HLA-A2.1 transgenic mouse islets by alloreactive human lymphocytes in immunodeficient NOD-scid and NOD-Rag1(null)Prf1(null) mice.
    Banuelos SJ; Shultz LD; Greiner DL; Burzenski LM; Gott B; Lyons BL; Rossini AA; Appel MC
    Clin Immunol; 2004 Sep; 112(3):273-83. PubMed ID: 15308121
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Parameters for establishing humanized mouse models to study human immunity: analysis of human hematopoietic stem cell engraftment in three immunodeficient strains of mice bearing the IL2rgamma(null) mutation.
    Brehm MA; Cuthbert A; Yang C; Miller DM; DiIorio P; Laning J; Burzenski L; Gott B; Foreman O; Kavirayani A; Herlihy M; Rossini AA; Shultz LD; Greiner DL
    Clin Immunol; 2010 Apr; 135(1):84-98. PubMed ID: 20096637
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Non-obese diabetic-recombination activating gene-1 (NOD-Rag1 null) interleukin (IL)-2 receptor common gamma chain (IL2r gamma null) null mice: a radioresistant model for human lymphohaematopoietic engraftment.
    Pearson T; Shultz LD; Miller D; King M; Laning J; Fodor W; Cuthbert A; Burzenski L; Gott B; Lyons B; Foreman O; Rossini AA; Greiner DL
    Clin Exp Immunol; 2008 Nov; 154(2):270-84. PubMed ID: 18785974
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunoglobulin-like transcript 3-Fc suppresses T-cell responses to allogeneic human islet transplants in hu-NOD/SCID mice.
    Vlad G; D'Agati VD; Zhang QY; Liu Z; Ho EK; Mohanakumar T; Hardy MA; Cortesini R; Suciu-Foca N
    Diabetes; 2008 Jul; 57(7):1878-86. PubMed ID: 18420485
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A new Hu-PBL model for the study of human islet alloreactivity based on NOD-scid mice bearing a targeted mutation in the IL-2 receptor gamma chain gene.
    King M; Pearson T; Shultz LD; Leif J; Bottino R; Trucco M; Atkinson MA; Wasserfall C; Herold KC; Woodland RT; Schmidt MR; Woda BA; Thompson MJ; Rossini AA; Greiner DL
    Clin Immunol; 2008 Mar; 126(3):303-14. PubMed ID: 18096436
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development of novel major histocompatibility complex class I and class II-deficient NOD-SCID IL2R gamma chain knockout mice for modeling human xenogeneic graft-versus-host disease.
    Pino S; Brehm MA; Covassin-Barberis L; King M; Gott B; Chase TH; Wagner J; Burzenski L; Foreman O; Greiner DL; Shultz LD
    Methods Mol Biol; 2010; 602():105-17. PubMed ID: 20012395
    [TBL] [Abstract][Full Text] [Related]  

  • 9. New mouse model to study islet transplantation in insulin-dependent diabetes mellitus.
    Mathews CE; Langley SH; Leiter EH
    Transplantation; 2002 Apr; 73(8):1333-6. PubMed ID: 11981430
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hyperglycemia-induced proliferation of adult human beta cells engrafted into spontaneously diabetic immunodeficient NOD-Rag1null IL2rγnull Ins2Akita mice.
    Diiorio P; Jurczyk A; Yang C; Racki WJ; Brehm MA; Atkinson MA; Powers AC; Shultz LD; Greiner DL; Bortell R
    Pancreas; 2011 Oct; 40(7):1147-9. PubMed ID: 21926555
    [No Abstract]   [Full Text] [Related]  

  • 11. Ex vivo expanded human regulatory T cells delay islet allograft rejection via inhibiting islet-derived monocyte chemoattractant protein-1 production in CD34+ stem cells-reconstituted NOD-scid IL2rγnull mice.
    Xiao F; Ma L; Zhao M; Huang G; Mirenda V; Dorling A; Lechler R; Lombardi G
    PLoS One; 2014; 9(3):e90387. PubMed ID: 24594640
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differences in suppressor of cytokine signaling-1 (SOCS-1) expressing islet allograft destruction in normal BALB/c and spontaneously-diabetic NOD recipient mice.
    Solomon M; Flodström-Tullberg M; Sarvetnick N
    Transplantation; 2005 May; 79(9):1104-9. PubMed ID: 15880051
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A humanized mouse model to study human immune response in xenotransplantation.
    Ji M; Jin X; Phillips P; Yi S
    Hepatobiliary Pancreat Dis Int; 2012 Oct; 11(5):494-8. PubMed ID: 23060394
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rapid destruction of encapsulated islet xenografts by NOD mice is CD4-dependent and facilitated by B-cells: innate immunity and autoimmunity do not play significant roles.
    Xu BY; Yang H; Serreze DV; MacIntosh R; Yu W; Wright JR
    Transplantation; 2005 Aug; 80(3):402-9. PubMed ID: 16082337
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human lymphoid and myeloid cell development in NOD/LtSz-scid IL2R gamma null mice engrafted with mobilized human hemopoietic stem cells.
    Shultz LD; Lyons BL; Burzenski LM; Gott B; Chen X; Chaleff S; Kotb M; Gillies SD; King M; Mangada J; Greiner DL; Handgretinger R
    J Immunol; 2005 May; 174(10):6477-89. PubMed ID: 15879151
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Implications of endoplasmic reticulum stress and beta-cell loss in immunodeficient diabetic NRG-Akita mice for understanding monogenic diabetes.
    M Rashwan A; M A Abumandour M; Kandyel R; Choudhary OP; Soliman RM; El Sharaby A; Nomir AG
    Int J Surg; 2024 Feb; ():. PubMed ID: 38329104
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro xenorecognition of adult pig pancreatic islet cells by splenocytes from nonobese diabetic or non-diabetes-prone mice.
    Rivereau AS; You S; Lalain S; Gouin E; Saï P
    Transplantation; 1998 Sep; 66(5):633-8. PubMed ID: 9753345
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Resistance of spontaneously diabetic Ins2(akita) mice to allograft tolerance induced by anti-CD154 therapy.
    Bishop NH; Beard KS; Gill RG
    Transplant Proc; 2014; 46(6):2007-9. PubMed ID: 25131095
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Major histocompatibility complex class I-restricted infiltration and destruction of pancreatic islets by NOD mouse-derived beta-cell cytotoxic CD8+ T-cell clones in vivo.
    Utsugi T; Yoon JW; Park BJ; Imamura M; Averill N; Kawazu S; Santamaria P
    Diabetes; 1996 Aug; 45(8):1121-31. PubMed ID: 8690161
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term human CD34+ stem cell-engrafted nonobese diabetic/SCID/IL-2R gamma(null) mice show impaired CD8+ T cell maintenance and a functional arrest of immature NK cells.
    André MC; Erbacher A; Gille C; Schmauke V; Goecke B; Hohberger A; Mang P; Wilhelm A; Mueller I; Herr W; Lang P; Handgretinger R; Hartwig UF
    J Immunol; 2010 Sep; 185(5):2710-20. PubMed ID: 20668220
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.